Once a product has been recommended for listing by the CED, the Ministry may work with the manufacturer to achieve appropriate utilization and manage costs via negotiated agreements. Recommendations for Formulary listings are then forwarded to the Executive Officer for final approval.

• e-Formulary
• CED Recommendations and Executive Officer Decisions

See also :

• Common Drug Review (CDR) Process
• Ontario Drug Benefit (ODB) Review Process
• New Chemical Entity or Combination Drug Products (New Brand Name/Innovator Drug Products)
• Types of Listing Recommendations
• New Drug Funding Program for Cancer Care